EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Treatment strategies for clear cell renal cell carcinoma: Past, present and future

Junwei Yang, Kuansong Wang, Zhichun Yang

Frontiers in Oncology · 21.03.2023 · 13

DOI: 10.3389/fonc.2023.1133832 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 21.03.2023. Verfasst von Junwei Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, China. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clear cell renal cell carcinoma (ccRCC) is the most prevalent histological subtype of kidney cancer, which is prone to metastasis, recurrence, and resistance to radiotherapy and chemotherapy. The burden it places on human health due to its refractory nature and rising incidence rate is substantial. Researchers have recently determined the ccRCC risk factors and optimized the clinical therapy based on the disease’s underlying molecular mechanisms. In this paper, we review the established clinical therapies and novel potential therapeutic approaches for ccRCC, and we support the importance of investigating novel therapeutic options in the context of combining established therapies as a research hotspot, with the goal of providing diversified therapeutic options that promise to address the issue of drug resistance, with a view to the early realization of precision medicine and individualized treatment.

Schlagwörter

Stichwörter der Autor:innen

clear cell renal cell carcinomacytokineimmune checkpoint inhibitorimmunological substance modificationobesity paradoxrenal cancer stem cellstyrosine kinase inhibitor

Autor:innen und Institutionen

  • Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, China.
  • Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of Pathology, School of Basic Medical Science, Central South University, Changsha, Hunan, China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yang, J., Wang, K., & Yang, Z. (2023). Treatment strategies for clear cell renal cell carcinoma: Past, present and future. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1133832

Vancouver

Yang J, Wang K, Yang Z. Treatment strategies for clear cell renal cell carcinoma: Past, present and future. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1133832

BibTeX
@article{Yang2023,
  author = {Yang, Junwei and Wang, Kuansong and Yang, Zhichun},
  title = {Treatment strategies for clear cell renal cell carcinoma: Past, present and future},
  journal = {Frontiers in Oncology},
  year = {2023},
  volume = {13},
  doi = {10.3389/fonc.2023.1133832}
}
Kostenlos starten →